Pharmaceutical

Alys Pharmaceuticals announces launch with $100m funding

Alys Pharmaceuticals has announced its launch with a R&D pipeline, backed by a $100m financing from Medicxi.

Feb 12, 2024 - 18:00
Alys Pharmaceuticals announces launch with $100m funding
Alys Pharmaceuticals has announced its launch with a R&D pipeline, backed by a $100m financing from Medicxi.
Read the original article

Tags:

Previous Article

How AI data management can transform your clinical trial 

Next Article

MHRA agrees licence change for Pfizer-BioNTech’s Comirnaty vaccine

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Sanofi’s $17bn sale of Opella to US investors advances following government deal

Sanofi’s $17bn sale of Opella to US investors advances ...

Oct 22, 2024

FDA grants priority review for Zealand Pharma’s dasiglucagon

FDA grants priority review for Zealand Pharma’s dasiglu...

Aug 30, 2023

Amarin restructures to counter downturn following Vascepa generics

Amarin restructures to counter downturn following Vasce...

Jul 19, 2023